Big Rounds, Big Bucks For Biotechs In 2015
This article was originally published in Start Up
Gurnet Capital's $600 million commitment to Boston Pharmaceuticals Inc. caps what has been a banner year for huge private biotech financings. Boston Pharma's is the biggest private round of the year so far, but it has plenty of company.
Register for our free email digests: